Larry Robbins portfolio, Q2 2026
Glenview Capital Management · 13F for the quarter ending Jun 30, 2026
For Q2 2026, Glenview Capital Management reported $5B across 42 US-listed positions, led by GPN (12.9%), CVS (10.0%) and THC (8.4%). Compared with its filing for Q1 2026, Larry Robbins opened 12 new positions, added to 14, reduced 15 and sold out of 11; 1 position did not change.
The largest purchase was a new position in A ($261.6M); the largest sale, a reduction of CVS ($348.8M).
This is the latest filing on file; the main portfolio page shows the same holdings against today's prices.
Key facts
- 13F portfolio value
- $5BQ2 2026
- Positions
- 42
- Largest holding
- GPN 12.9%
- New positions
- 12
- Sold out
- 11
- Filed
- Aug 14, 2026
Holdings as of (Q2 2026), filed with the SEC on . Changes are measured against the filing for Mar 31, 2026. Every tracked investor's Q2 2026 13F.
Bought and sold in Q2 2026
| Stock | Move | Shares | Size | Of portfolio |
|---|---|---|---|---|
| CVS Health CorpCVS | ▼ Reduced 41% | −3.37M | $348.8M | 6.97% |
| Agilent Technologies IncA | ▲ New | +1.97M | $261.6M | 5.23% |
| Advanced Micro Devices IncAMD | ▼ Reduced 54% | −352.38K | $204.7M | 4.09% |
| Thermo Fisher Scientific IncTMO | ▲ Added 150% | +376.72K | $188.9M | 3.77% |
| Danaher CorpDHR | ▲ Added 633% | +989.7K | $188.5M | 3.77% |
| Global PMTS IncGPN | ▲ Added 40% | +2.55M | $184.8M | 3.69% |
| Tenet Healthcare CorpTHC | ▲ Added 47% | +710.81K | $133M | 2.66% |
| Meta Platforms IncMETA | ▲ Added 191% | +234.18K | $131.9M | 2.63% |
| DXC Technology CoDXC | ▼ Sold out | −8.9M | $111.8M | 2.23% |
| Applied Materials IncAMAT | ▼ Reduced 67% | −132.01K | $95.4M | 1.91% |
| Zoominfo Technologies IncGTM | ▼ Sold out | −15.91M | $95.1M | 1.90% |
| Centene CorpCNC | ▼ Reduced 41% | −1.33M | $85.2M | 1.70% |
| Eli Lilly & CoLLY | ▲ New | +57.77K | $69.3M | 1.38% |
| Teva Pharmaceutical IndustriesTEVA | ▼ Reduced 24% | −1.58M | $53.5M | 1.07% |
| Amazon.com IncAMZN | ▲ Added 20% | +212.42K | $50.6M | 1.01% |
| MKS IncMKSI | ▲ New | +98.53K | $43.8M | 0.88% |
| Stmicroelectronics N VSTM | ▲ New | +560.06K | $41.9M | 0.84% |
| AbbVie IncABBV | ▲ New | +148.91K | $37.5M | 0.75% |
| Onto Innovation IncONTO | ▼ Reduced 31% | −93.93K | $35.5M | 0.71% |
| US Foods Holding CorpUSFD | ▼ Sold out | −384.01K | $35.4M | 0.71% |
| AstraZeneca PLCAZN | ▲ New | +184.28K | $34.9M | 0.70% |
| Zillow Group IncZ | ▼ Sold out | −789.67K | $32.7M | 0.65% |
| Humana IncHUM | ▼ Reduced 24% | −80.68K | $32M | 0.64% |
| Lithia Motors IncLAD | ▼ Sold out | −127.61K | $31.9M | 0.64% |
| Element Solutions IncESI | ▼ Reduced 39% | −634.1K | $30.3M | 0.60% |
| Genius Sports LtdGENI | ▲ Added 58% | +4.93M | $29.9M | 0.60% |
| National Vision Holdings IncEYE | ▲ Added 98% | +1.54M | $29.2M | 0.58% |
| Lionsgate Studios CorpLION | ▼ Sold out | −2.78M | $26.6M | 0.53% |
| Digitalocean Holdings IncDOCN | ▼ Reduced 66% | −165.19K | $25.9M | 0.52% |
| Elevance HealthELV | ▲ New | +66.6K | $25.8M | 0.51% |
| Uber Technologies IncUBER | ▲ Added 23% | +337.73K | $24.4M | 0.49% |
| Myriad Genetics IncMYGN | ▼ Sold out | −5.41M | $24.4M | 0.49% |
| Microchip Technology IncMCHP | ▲ New | +265.58K | $24.2M | 0.48% |
| The Cigna GroupCI | ▼ Reduced 17% | −86.62K | $23.9M | 0.48% |
| Dicks Sporting Goods IncDKS | ▲ Added 34% | +102.16K | $23.2M | 0.46% |
| Surgery Partners IncSGRY | ▼ Sold out | −1.8M | $21.5M | 0.43% |
| Akamai Technologies IncAKAM | ▼ Sold out | −156.45K | $18M | 0.36% |
| Intel CorpINTC | ▼ Sold out | −399.51K | $17.6M | 0.35% |
| Bruker CorpBRKR | ▲ New | +252.17K | $15.2M | 0.30% |
| Novartis AGNVS | ▲ New | +86.91K | $13.6M | 0.27% |
| Block IncXYZ | ▼ Reduced 12% | −167.43K | $12.7M | 0.25% |
| Viatris IncVTRS | ▲ Added 8.7% | +790.17K | $12.5M | 0.25% |
| Baker Hughes CoBKR | ▲ Added 63% | +189.84K | $10.5M | 0.21% |
| Biogen IncBIIB | ▼ Sold out | −57.02K | $10.5M | 0.21% |
| Bio-Techne CorpTECH | ▼ Reduced 69% | −127.99K | $9M | 0.18% |
| Cisco Systems IncCSCO | ▲ Added 22% | +73.51K | $8.6M | 0.17% |
| Boston Scientific CorpBSX | ▲ New | +113.1K | $4.8M | 0.10% |
| Six Flags Entertainment CorpFUN | ▼ Reduced 9.2% | −205.33K | $4.4M | 0.09% |
| Cardinal Health IncCAH | ▲ New | +18.02K | $4.3M | 0.09% |
| Primo Brands CorporationPRMB | ▼ Reduced 24% | −126.08K | $3.1M | 0.06% |
| United Airls Hldgs IncUAL | ▼ Reduced 0.4% | −2.12K | $288.8K | 0.01% |
| Bausch Plus Lomb CorpBLCO | ▲ Added 0.4% | +7.65K | $126.7K | 0.00% |
Holdings at the quarter's end
| # | Stock | Sector | Share of portfolio | Value | Shares | Reported price | Held | Since Q1 2026 |
|---|---|---|---|---|---|---|---|---|
| 1 | Global PMTS IncGPN | Financials | 12.9% | $646.3M | 8.91M | $72.56 | 9+ qtrs | ▲ Added 40% |
| 2 | CVS Health CorpCVS | Health Care | 9.97% | $499.1M | 4.82M | $103.45 | 9+ qtrs | ▼ Reduced 41% |
| 3 | Tenet Healthcare CorpTHC | Health Care | 8.36% | $418.2M | 2.24M | $187.08 | 9+ qtrs | ▲ Added 47% |
| 4 | Thermo Fisher Scientific IncTMO | Health Care | 6.28% | $314.5M | 627.24K | $501.36 | 5 qtrs | ▲ Added 150% |
| 5 | Amazon.com IncAMZN | Consumer Discretionary | 6.05% | $303.1M | 1.27M | $238.34 | 9+ qtrs | ▲ Added 20% |
| 6 | Agilent Technologies IncA | Health Care | 5.23% | $261.6M | 1.97M | $132.83 | 1 qtr | New |
| 7 | Danaher CorpDHR | Health Care | 4.36% | $218.3M | 1.15M | $190.48 | 5 qtrs | ▲ Added 633% |
| 8 | Meta Platforms IncMETA · CL A | Communication | 4.02% | $201M | 356.84K | $563.29 | 6 qtrs | ▲ Added 191% |
| 9 | Advanced Micro Devices IncAMD | Technology | 3.46% | $173.3M | 298.41K | $580.91 | 3 qtrs | ▼ Reduced 54% |
| 10 | Teva Pharmaceutical IndustriesTEVA · SPONSORED ADS | Health Care | 3.44% | $172.1M | 5.08M | $33.88 | 9+ qtrs | ▼ Reduced 24% |
| 11 | Viatris IncVTRS | Health Care | 3.13% | $156.9M | 9.88M | $15.88 | 9+ qtrs | ▲ Added 8.7% |
| 12 | Uber Technologies IncUBER | Industrials | 2.59% | $129.4M | 1.79M | $72.16 | 9+ qtrs | ▲ Added 23% |
| 13 | Centene CorpCNC | Health Care | 2.42% | $121.1M | 1.89M | $64.19 | 4 qtrs | ▼ Reduced 41% |
| 14 | Butterfly Network IncBFLY | — | 2.41% | $120.7M | 14.34M | $8.42 | 9+ qtrs | No change |
| 15 | The Cigna GroupCI | Health Care | 2.27% | $113.6M | 412.22K | $275.68 | 9+ qtrs | ▼ Reduced 17% |
| 16 | Humana IncHUM | Health Care | 2.02% | $101M | 254.22K | $397.22 | 2 qtrs | ▼ Reduced 24% |
| 17 | Block IncXYZ · CL A | Technology | 1.82% | $91M | 1.2M | $76.00 | 4 qtrs | ▼ Reduced 12% |
| 18 | Dicks Sporting Goods IncDKS | Consumer Discretionary | 1.82% | $91M | 401.07K | $226.81 | 5 qtrs | ▲ Added 34% |
| 19 | Genius Sports LtdGENI · SHARES CL A | — | 1.63% | $81.8M | 13.5M | $6.06 | 3 qtrs | ▲ Added 58% |
| 20 | Onto Innovation IncONTO | Technology | 1.56% | $77.9M | 205.79K | $378.45 | 4 qtrs | ▼ Reduced 31% |
| 21 | Eli Lilly & CoLLY | Health Care | 1.38% | $69.3M | 57.77K | $1,199.43 | 1 qtr | New |
| 22 | United Airls Hldgs IncUAL | Industrials | 1.34% | $67.3M | 494.74K | $135.99 | 6 qtrs | ▼ Reduced 0.4% |
| 23 | National Vision Holdings IncEYE | — | 1.18% | $59M | 3.1M | $19.01 | 5 qtrs | ▲ Added 98% |
| 24 | Cisco Systems IncCSCO | Technology | 0.97% | $48.5M | 413.33K | $117.46 | 2 qtrs | ▲ Added 22% |
| 25 | Element Solutions IncESI | Materials | 0.95% | $47.5M | 994.58K | $47.75 | 9+ qtrs | ▼ Reduced 39% |
| 26 | Applied Materials IncAMAT | Technology | 0.94% | $47.1M | 65.2K | $723.00 | 3 qtrs | ▼ Reduced 67% |
| 27 | MKS IncMKSI | Industrials | 0.88% | $43.8M | 98.53K | $444.80 | 1 qtr | New |
| 28 | Six Flags Entertainment CorpFUN | — | 0.86% | $43M | 2.02M | $21.30 | 3 qtrs | ▼ Reduced 9.2% |
| 29 | Stmicroelectronics N VSTM · NY REGISTRY | Technology | 0.84% | $41.9M | 560.06K | $74.89 | 1 qtr | New |
| 30 | AbbVie IncABBV | Health Care | 0.75% | $37.5M | 148.91K | $251.64 | 1 qtr | New |
| 31 | AstraZeneca PLCAZN · ORD | Health Care | 0.70% | $34.9M | 184.28K | $189.62 | 1 qtr | New |
| 32 | Bausch Plus Lomb CorpBLCO | Health Care | 0.64% | $31.8M | 1.92M | $16.56 | 6 qtrs | ▲ Added 0.4% |
| 33 | Baker Hughes CoBKR · CL A | Energy | 0.55% | $27.4M | 493.52K | $55.50 | 2 qtrs | ▲ Added 63% |
| 34 | Elevance HealthELV | Health Care | 0.51% | $25.8M | 66.6K | $386.73 | 1 qtr | New |
| 35 | Microchip Technology IncMCHP | Technology | 0.48% | $24.2M | 265.58K | $91.20 | 1 qtr | New |
| 36 | Bruker CorpBRKR | Health Care | 0.30% | $15.2M | 252.17K | $60.18 | 1 qtr | New |
| 37 | Novartis AGNVS · SPONSORED ADR | Health Care | 0.27% | $13.6M | 86.91K | $156.72 | 1 qtr | New |
| 38 | Digitalocean Holdings IncDOCN | Technology | 0.27% | $13.3M | 84.81K | $157.03 | 3 qtrs | ▼ Reduced 66% |
| 39 | Primo Brands CorporationPRMB · CLASS A COM SHS | Consumer Staples | 0.20% | $9.9M | 404.97K | $24.44 | 2 qtrs | ▼ Reduced 24% |
| 40 | Boston Scientific CorpBSX | Health Care | 0.10% | $4.8M | 113.1K | $42.68 | 1 qtr | New |
| 41 | Cardinal Health IncCAH | Health Care | 0.09% | $4.3M | 18.02K | $237.56 | 1 qtr | New |
| 42 | Bio-Techne CorpTECH | Health Care | 0.08% | $4.1M | 58.32K | $70.65 | 4 qtrs | ▼ Reduced 69% |
By sector
| Sector | Share of portfolio | Value | Positions |
|---|---|---|---|
| Health Care | 52.3% | $2.6B | 20 |
| Financials | 12.9% | $646.3M | 1 |
| Technology | 10.3% | $517.4M | 8 |
| Consumer Discretionary | 7.87% | $394.1M | 2 |
| Industrials | 4.80% | $240.5M | 3 |
| Communication | 4.02% | $201M | 1 |
| Materials | 0.95% | $47.5M | 1 |
| Energy | 0.55% | $27.4M | 1 |
| Consumer Staples | 0.20% | $9.9M | 1 |
| No sector on file | 6.08% | $304.4M | 4 |
Questions and answers
What did Larry Robbins own in Q2 2026?
Glenview Capital Management's 13F for Q2 2026 lists 42 positions worth $5B. The largest: GPN (12.9%), CVS (10.0%), THC (8.4%), TMO (6.3%), AMZN (6.1%).
What did Larry Robbins buy in Q2 2026?
The largest purchases, by the shares bought at the quarter-end price the filing implies: A (new, $261.6M), TMO (added, $188.9M), DHR (added, $188.5M), GPN (added, $184.8M), THC (added, $133M), META (added, $131.9M).
What did Larry Robbins sell in Q2 2026?
The largest sales: CVS (reduced, $348.8M), AMD (reduced, $204.7M), DXC (sold out, $111.8M), AMAT (reduced, $95.4M), GTM (sold out, $95.1M), CNC (reduced, $85.2M).
When was this filing made?
Glenview Capital Management filed its 13F for the quarter ending Jun 30, 2026 on Aug 14, 2026. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.
Learn
Cite this page
Funkfolio, “Larry Robbins portfolio, Q2 2026: Glenview Capital Management 13F holdings”, data as of 14 August 2026. https://funkfolio.com/gurus/larry-robbins/2026-q2
Underlying data: SEC EDGAR, Form 13F-HR of Glenview Capital Management (CIK 1138995) for the period ending Jun 30, 2026.
Source: SEC EDGAR, Form 13F-HR for Glenview Capital Management (CIK 1138995), period ending Jun 30, 2026, filed Aug 14, 2026. Changes compare share counts with the filing for Mar 31, 2026; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $5B reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 9 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. 3 option positions in the filing are not shown. Not a live portfolio and not advice.